Boulder, Colorado
United States
22
2014-09-18
20
2015-11-17
These are the the leading inventors for applications assigned to N30 PHARMACEUTICALS, INC.:
N30 PHARMACEUTICALS, INC. based in Boulder, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
S-nitrosoglutathione reductase inhibitors
#2 | 2014-08-21 ✅ Patent 9,067,893 granted on 2015-06-30Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors
#3 | 2014-07-10 ✅ Patent 8,846,736 granted on 2014-09-30Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#4 | 2014-07-10 ✅ Patent 9,138,427 granted on 2015-09-22Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#5 | 2014-06-12Chromone Inhibitors of S-Nitrosoglutathione Reductase
#6 | 2014-06-05 ✅ Patent 8,957,105 granted on 2015-02-17Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#7 | 2014-04-24Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents for Liver Toxicity
#8 | 2014-02-27 ✅ Patent 8,859,611 granted on 2014-10-14Thiophene inhibitors of S-nitrosoglutathione reductase
#9 | 2013-10-17 ✅ Patent 8,669,381 granted on 2014-03-11Chromone inhibitors of S-nitrosoglutathione reductase
#10 | 2013-10-03 ✅ Patent 8,785,643 granted on 2014-07-22Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
#11 | 2013-09-26 ✅ Patent 8,686,015 granted on 2014-04-01Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#12 | 2013-07-11 ✅ Patent 8,921,562 granted on 2014-12-30Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
#13 | 2013-05-23 ✅ Patent 8,906,933 granted on 2014-12-09Dihydropyrimidin-2(1H)-one compounds as neurokinin-3 receptor antagonists
#14 | 2013-04-18 ✅ Patent 8,946,434 granted on 2015-02-03Dihydropyridin-2(1H)-one compound as S-nirtosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists
#15 | 2012-11-22 ✅ Patent 8,481,590 granted on 2013-07-09Chromone inhibitors of S-nitrosoglutathione reductase
#16 | 2012-11-15 ✅ Patent 8,759,548 granted on 2014-06-24S-nitrosoglutathione reductase inhibitors
#17 | 2012-09-27 ✅ Patent 8,586,624 granted on 2013-11-19Thiophene inhibitors of S-nitrosoglutathione reductase
#18 | 2012-08-16 ✅ Patent 8,741,915 granted on 2014-06-03Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors
#19 | 2011-06-16 ✅ Patent 8,673,961 granted on 2014-03-18Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#20 | 2011-06-16 ✅ Patent 8,691,816 granted on 2014-04-08Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#21 | 2011-06-09 ✅ Patent 8,470,857 granted on 2013-06-25Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#22 | 2011-06-09 ✅ Patent 8,642,628 granted on 2014-02-04Pyrrole inhibitors of S-nitrosoglutathione reductase
Also check out N30 Pharmaceuticals, Inc.'s (Boulder, United States) applicant profile with 13 patent applications submitted.
18626 ⎘